title: Studying HCV cell entry with HCV pseudoparticles (HCVpp).
abstract: HCV infection leads in 50 to 80% of cases to chronic hepatitis, liver cirrhosis, or hepatocellular carcinoma. Interferons and the nucleoside analog ribavirin form the basis for treatment but are not sufficiently effective and have numerous side effects. Although about 300 million people worldwide are estimated to be infected, the characterization of HCV biology and associated pathologies and development of new therapeutics have been slow. Systems that support HCV replication and particle formation in vitro have emerged only over the last few years, over 15 years after the discovery of the virus. The available infection models have remained limited to chimpanzee (1) and immunodeficient mice carrying engrafted human liver cells (2). HCV pseudoparticles (HCVpp) were the first in vitro infection system to become available for investigation of entry and neutralization of this major human pathogen. HCVpp are formed by incorporation of the full-length hepatitis C virus glycoproteins E1 and E2 onto lenti- or retroviral core particles. HCVpp have been validated by many research groups, closely mimic the functionality of the wild-type virus in terms of cell entry and neutralization, and have even been used to isolate the recent HCV receptor Claudin-1. HCVpp are a useful model system not only because of the functional conservation of the envelope glycoproteins with those of the wild-type virus, but also because the retro- or lentiviral vectors used to form them offer of a number of significant technical advantages.
authors.affiliation: ENS de Lyon, Lyon, France.
authors.forename: Birke
authors.initials: B
authors.lastname: Bartosch
authors.forename: François-Loïc
authors.initials: FL
authors.lastname: Cosset
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D032701:Biomimetics / Q000379:methods*; D018929:Cell Culture Techniques; D002460:Cell Line; D016174:Hepacivirus / Q000235:genetics / Q000502:physiology*; D006526:Hepatitis C / Q000378:metabolism / Q000821:virology; D006801:Humans; D013997:Time Factors; D019076:Transgenes / Q000235:genetics; D014764:Viral Proteins / Q000378:metabolism; D014771:Virion / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D053586:Virus Internalization
chemical_list: D015415:Biomarkers; D014764:Viral Proteins